FDA Needs Six Months To Review Labopharm’s Once-Daily Tramadol
This article was originally published in The Pink Sheet Daily
Executive Summary
Cipher’s competing tramadol formulation has a user fee date more than a month ahead of the June deadline for Labopharm’s product.